A critical advance in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor protector protein is frequently inactivated in several forms of tumors, causing https://dailybookmarkhit.com/story22042931/nanobodies-revive-tumor-suppressor-p53-the-new-approach-for-malignant-therapy